The Clorox CompanyCLXNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -15.28% | -8.05% | +4.47% | -18.90% | -0.77% |
| Gross Profit Growth | -14.44% | -2.89% | +4.78% | -26.49% | -1.77% |
| EBITDA Growth | +41.89% | +700.00% | +37.43% | -25.88% | -5.40% |
| Operating Income Growth | -27.64% | +9.17% | +31.87% | -58.31% | +3.43% |
| Net Income Growth | +107.53% | +0.00% | +53.70% | -19.19% | -18.65% |
| EPS Growth | +108.00% | +0.00% | +55.17% | -18.75% | -17.31% |
| EPS Diluted Growth | +105.33% | +0.00% | +54.91% | -17.72% | -16.23% |
| Weighted Average Shares Growth | -0.33% | -0.71% | -0.91% | -0.94% | -1.75% |
| Weighted Average Shares Diluted Growth | +0.03% | -0.15% | -1.05% | -1.33% | -2.20% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +17.65% | +57.14% | -13.53% | -57.92% | +72.78% |
| Free Cash Flow Growth | +25.74% | +83.46% | -15.44% | -68.68% | +111.81% |
| Receivables Growth | -11.19% | -11.29% | +18.13% | +18.15% | +11.28% |
| Inventory Growth | -9.62% | -5.79% | -17.90% | -2.86% | +2.70% |
| Asset Growth | -5.60% | -5.05% | -3.30% | +0.56% | +0.65% |
| Book Value per Share Growth | +0.00% | -70.12% | -1.24% | +0.00% | +0.00% |
| Debt Growth | -1.18% | -2.52% | -0.79% | +6.73% | +4.04% |
| R&D Expense Growth | -3.13% | -15.63% | -3.03% | -9.68% | -6.45% |
| SG&A Expenses Growth | -6.73% | -7.24% | -11.22% | -8.09% | -4.03% |